Lycia Therapeutics, a Phase 1 biotech developing protein degraders for food allergy and Graves' disease, announced terms for its IPO on Tuesday.The South San Francisco, CA-based company plans to raise ...

Gravitics Holdings, which develops space structures and orbital systems, lowered the proposed deal size for its upcoming IPO ...

Rezera, a Phase 3-ready biotech developing oral NLRP3 inhibitors for inflammatory diseases, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering.Rezera is ...

Klook Technology, a pan-Asian online travel booking platform, withdrew its plans for an initial public offering on Friday.

Africa-linked IPOs are having a strong year. Seven companies with significant African operations have raised at least $100 ...

Three IPOs and two SPACs priced this week, and two SPACs submitted filings.City Therapeutics (CTY) priced its upsized IPO at the midpoint to raise $200 million at a $1.0 billion market cap.

Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, raised $150 million ...

SPACCircle Acquisition, a blank check company targeting digital asset, technology, and healthcare businesses, lowered the ...

No IPOs are currently scheduled for the week ahead as the year’s next mega IPO potentially comes into view.Reportedly targeting a listing in mid-November, Anthropic could file as early as this coming ...

Amaero, a producer of titanium and refractory metal powders for defense and aerospace 3D printing, raised $20 million in its ...

Kepuni Holdings, a Chinese manufacturer of nautical communications and electronic equipment, withdrew its plans for an ...

EuroSPAC Acquisition, a blank check company led by the CEO of shipping company Euroseas targeting the industrials sector, ...